The mGlu2/3 Receptor Agonists LY354740 and LY379268 Differentially Regulate Restraint-Stress-Induced Expression of c-Fos in Rat Cerebral Cortex
Neuroscience Journal · 2013
DOI: 10.1155/2013/736439 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuroscience Journal, 2013. Verfasst von M M Menezes und 6 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience Discovery, Eli Lilly & Company, Indianapolis, IN 46285, USA. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Danish Strategic Research Council.
Abstract (Originalsprache)
Metabotropic glutamate 2/3 (mGlu2/3) receptors have emerged as potential therapeutic targets due to the ability of mGlu2/3 receptor agonists to modulate excitatory transmission at specific synapses. LY354740 and LY379268 are selective and potent mGlu2/3 receptor agonists that show both anxiolytic- and antipsychotic-like effects in animal models. We compared the efficacy of LY354740 and LY379268 in attenuating restraint-stress-induced expression of the immediate early gene c-Fos in the rat prelimbic (PrL) and infralimbic (IL) cortex. LY354740 (10 and 30 mg/kg, i.p.) showed statistically significant and dose-related attenuation of stress-induced increase in c-Fos expression, in the rat cortex. By contrast, LY379268 had no effect on restraint-stress-induced c-Fos upregulation (0.3–10 mg/kg, i.p.). Because both compounds inhibit serotonin 2A receptor ( 5-HT 2A R )-induced c-Fos expression, we hypothesize that LY354740 and LY379268 have different in vivo properties and that 5-HT 2A R activation and restraint stress induce c-Fos through distinct mechanisms.
Autor:innen und Institutionen
- Neuroscience Discovery, Eli Lilly & Company, Indianapolis, IN 46285, USA.
- Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, 2100 Copenhagen, Denmark.
- Neuroscience Discovery, Eli Lilly & Company, Indianapolis, IN 46285, USA ; Abbott Laboratories, Global Pharmaceutical Research and Development, Neuroscience Clinical Development, Abbott Park, IL 60064-6075, USA.
Förderung
- Danish Strategic Research Council
Zitieren
APA
Menezes, M. M., Santini, M. A., Benvenga, M. J., Marek, G. J., Merchant, K. M., Mikkelsen, J. D., & Svensson, K. A. (2013). The mGlu2/3 Receptor Agonists LY354740 and LY379268 Differentially Regulate Restraint-Stress-Induced Expression of c-Fos in Rat Cerebral Cortex. Neuroscience Journal. https://doi.org/10.1155/2013/736439
Vancouver
Menezes MM, Santini MA, Benvenga MJ, Marek GJ, Merchant KM, Mikkelsen JD, et al. The mGlu2/3 Receptor Agonists LY354740 and LY379268 Differentially Regulate Restraint-Stress-Induced Expression of c-Fos in Rat Cerebral Cortex. Neuroscience Journal. 2013. doi:10.1155/2013/736439
BibTeX
@article{Menezes2013,
author = {Menezes, M M and Santini, M A and Benvenga, M J and Marek, G J and Merchant, K M and Mikkelsen, J D and Svensson, K A},
title = {The mGlu2/3 Receptor Agonists LY354740 and LY379268 Differentially Regulate Restraint-Stress-Induced Expression of c-Fos in Rat Cerebral Cortex},
journal = {Neuroscience Journal},
year = {2013},
doi = {10.1155/2013/736439}
}
EUVIMED